Skip to main content
Lindsey Roeker, MD, Oncology, New York, NY

LindseyElizabethRoekerMD

Oncology New York, NY

Hematologic Oncology

Assistant Attending Physician

Overview of Dr. Roeker

Dr. Lindsey Roeker is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Mayo Clinic College of Medicine and Science and has been in practice 2 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 70 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2014 - 2017
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 2014

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2017 - 2026
  • MN State Medical License
    MN State Medical License 2024 - 2025
  • NJ State Medical License
    NJ State Medical License 2020 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Veneto-STOP Study: Sequential Assessment of Minimal Residual Disease By Next Generation Sequencing to Optimize Outcomes and Minimize Exposure in Venetoclax-Treated CLL...
    Lindsey E. Roeker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Veneto-STOP Study: Sequential Assessment of Minimal Residual Disease By Next Generation Sequencing to Optimize Outcomes and Minimize Exposure in Venetoclax-Treated CLL...
    Lindsey E. Roeker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study
    Lindsey E. Roeker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • CLL and COVID-19: Outcome Trends and Lessons Learned
    CLL and COVID-19: Outcome Trends and Lessons LearnedDecember 8th, 2021